CAPRICOR THERAPEUTICS, INC. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Capricor Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Capricor Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -113 %, a 81.7% increase year-over-year.
  • Capricor Therapeutics, Inc. annual Return On Equity for 2023 was -300 %, a 82.2% decline from 2022.
  • Capricor Therapeutics, Inc. annual Return On Equity for 2022 was -164 %, a 183% decline from 2021.
  • Capricor Therapeutics, Inc. annual Return On Equity for 2021 was -58.1 %, a 6.2% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -300 -135 -82.2% Jan 1, 2023 Dec 31, 2023
2022 -164 -106 -183% Jan 1, 2022 Dec 31, 2022
2021 -58.1 -3.39 -6.2% Jan 1, 2021 Dec 31, 2021
2020 -54.7 +130 +70.4% Jan 1, 2020 Dec 31, 2020
2019 -185 +6.22 +3.25% Jan 1, 2019 Dec 31, 2019
2018 -191 -48.8 -34.2% Jan 1, 2018 Dec 31, 2018
2017 -143 -883 -119% Jan 1, 2017 Dec 31, 2017
2016 741 +1.14K Jan 1, 2016 Dec 31, 2016
2015 -403 -563 -350% Jan 1, 2015 Dec 31, 2015
2014 161 -733 -82% Jan 1, 2014 Dec 31, 2014
2013 894 +1.04K Jan 1, 2013 Dec 31, 2013
2012 -145 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.